222 related articles for article (PubMed ID: 30372724)
21. New concepts in the molecular understanding of uveal melanoma.
Reichstein D
Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
24. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
[TBL] [Abstract][Full Text] [Related]
26. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.
Harbour JW; Chao DL
Ophthalmology; 2014 Jun; 121(6):1281-8. PubMed ID: 24480708
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
28. Metastatic disease in uveal melanoma: importance of a genetic profile?
Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
[TBL] [Abstract][Full Text] [Related]
29. Animal-type malignant melanoma associated with nevus of Ota in the orbit of a Japanese woman: a case report.
Nitta K; Kashima T; Mayuzumi H; Akiyama H; Miyanaga T; Hirato J; Kishi S
Melanoma Res; 2014 Jun; 24(3):286-9. PubMed ID: 24686419
[TBL] [Abstract][Full Text] [Related]
30. Giant Blue Nevus: A New Association to Nevus of Ota.
Medel R; Vasquez L; Fernandez J; Huguet P; Pamias J
Orbit; 2015; 34(4):223-8. PubMed ID: 26121271
[TBL] [Abstract][Full Text] [Related]
31. [Primary intracranial malignant melanoma associated with nevus of Ota: a case report].
Kabuto M; Hayashi M; Kawano H; Kobayashi H; Shirasaki N; Hirose S; Kubota T; Sugihara H
No Shinkei Geka; 1988 Jun; 16(7):875-80. PubMed ID: 3065671
[TBL] [Abstract][Full Text] [Related]
32. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in prognostic and predictive testing in uveal melanoma.
Field MG; Harbour JW
Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
[TBL] [Abstract][Full Text] [Related]
34. Uveal Melanoma:
Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
[TBL] [Abstract][Full Text] [Related]
35. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
36. [Nevus of Ota. Presentation of a case associated with a cellular blue nevus with suspected malignant degeneration and review of the literature].
Bisceglia M; Carosi I; Fania M; Di Ciommo A; Lomuto M
Pathologica; 1997 Apr; 89(2):168-74. PubMed ID: 9411364
[TBL] [Abstract][Full Text] [Related]
37. The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.
Li Y; He J; Qiu C; Shang Q; Qian G; Fan X; Ge S; Jia R
J Cell Biochem; 2019 Apr; 120(4):5766-5776. PubMed ID: 30320917
[TBL] [Abstract][Full Text] [Related]
38. Intracranial meningeal melanocytoma associated with nevus of Ota.
Pan H; Wang H; Fan Y
J Clin Neurosci; 2011 Nov; 18(11):1548-50. PubMed ID: 21924617
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma in a Hispanic male with nevus of Ota.
Shaffer D; Walker K; Weiss GR
Dermatology; 1992; 185(2):146-50. PubMed ID: 1421629
[TBL] [Abstract][Full Text] [Related]
40. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
